The renowned global medical device company has a market capitalization of $214.01 million. The company projects 18.6% growth over the next five years. Nevro’s earnings surpassed the Zacks Consensus ...
AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, ATX01, announced today the completion of the Last Patient Last ...
At Regenerative Neuropathy of O’Fallon, Illinois, highly trained doctors are using a cutting-edge treatment and successfully slowing and often reversing the disease without addictive medications. The ...